Friday, April 28, 2006

Stem Cell Innovations files patent application

NJBiz reports: Stem Cell Innovations has filed a patent application that seeks to protect the company’s method for turning its proprietary stem cells into certain types of brain cells. The stem cells, culled from aborted fetuses, will be used in the company’s drug discovery and toxicology platform.

Based in Houston, Texas, with an office in Scotch Plains, Stem Cell Innovations is also using the cells in therapeutic research of multiple diseases and debilitating conditions. In addition, the company plans to make the cells available to universities and not-for-profit organizations.

“These cells have significant potential in both drug discovery and cell therapies to treat diseases such as ALS, Parkinson's, Huntington's, multiple sclerosis, and spinal cord injury,” said James Kelly, CEO of Stem Cell Innovations. “We are already in discussions with companies that have expressed interest in these cells." Stem Cell Innovations shares rose 5 cents to $0.61 this morning.


Post a Comment

<< Home